| About: | Jinyu Bio-technology Co., Ltd. develops and evaluates vaccines and reagents for animal diseases. It offers vaccines for pigs to treat swine influenza, g E gene deletion, classical swine fever, porcine parvovirus and circovirus, foot-and-mouth disease, porcine reproductive and respiratory syndrome, pseudorabies, swine erysipelas, porcine pasteurella multocida triple foot-and-mouth disease type 0, swine erysipelas, porcine pasteurella multocida, porcine paratyphoid porcine circovirus, and porcine escherichia coli; ruminants vaccines for the treatment of foot-and-mouth disease type O and type A, bovine viral diarrhea/mucosal disease, infectious rhinotracheitis, goat pox, brucellosis, sheep plague, sudden death, lamb dysentery, and enterotoxemia. The company also sells poultry vaccines to treat recombinant avian influenza virus, Newcastle disease, infectious bronchitis, egg drop syndrome, avian influenza (H9 subtype), infectious bursal disease, infectious bronchitis, duck tembusu virus disease, and recombinant Newcastle disease virus; inactivated rabies vaccine; and diagnostic reagents, including foot-and-mouth disease type O liquid phase blocking ELISA antibody detection kit, foot-and-mouth disease type A liquid phase blocking ELISA antibody detection kit, classical swine fever E2 protein ELISA antibody detection kit, and foot-and-mouth disease type A virus monoclonal antibody competitive ELISA detection kit. In addition, it provides needle free injection, combined immunization, epidemic prevention guide, and diagnostic testing services. The company was founded in 1992 and is headquartered in Hohhot, China. |